| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2018 | NBIX Neurocrine Biosciences Inc | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 18,084 | $77.52 | $1,401,822.85 | -58.1% | |
| Jan 2, 2018 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | President &CEO | Sell | 21,906 | $47.91 | $1,049,516.46 | -9.7% | |
| Jan 2, 2018 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 50,000 | $7.05 | $352,680.00 | -0.9% | |
| Jan 2, 2018 | SUPN Supernus Pharmaceuticals, Inc. | Vaughn Victor | Sr. VP Of Sales | Sell | 55,000 | $40.11 | $2,206,308.50 | -85.5% | |
| Dec 29, 2017 | ALKS Alkermes Plc. | Brown Iain Michael | SVP Finance &CAO, Alks Inc. | Sell | 10,652 | $54.81 | $583,886.18 | -38.6% | |
| Dec 28, 2017 | PRGO Perrigo Co Plc | Kingma Todd W | Executive VP, General Counsel | Sell | 1,500 | $88.52 | $132,780.00 | -8.0% | |
| Dec 28, 2017 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 15,237 | $75.00 | $1,142,775.00 | -53.7% | |
| Dec 19, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $19.48 | $10,185.63 | -1.7% | |
| Dec 15, 2017 | RMTI Rockwell Medical, Inc. | Richmond David S. | 10% Owner, See Footnote 1 | Sell | 36 | $6.53 | $235.15 | - | |
| Dec 15, 2017 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 340 | $43.70 | $14,858.00 | -3.2% | |
| Dec 14, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Shohet Stephen B. | Director | Sell | 7,866 | $18.87 | $148,429.85 | -24.6% | |
| Dec 14, 2017 | PRGO Perrigo Co Plc | Wesolowski John | EVP, President Rx | Buy | 700 | $85.80 | $60,060.00 | +7,778% | |
| Dec 13, 2017 | DVAX Dynavax Technologies Corp | Coffman Robert | Senior Vice President | Sell | 7,500 | $18.90 | $141,750.00 | -54.3% | |
| Dec 13, 2017 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $88.20 | $17,639,176.00 | - | |
| Dec 13, 2017 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | President &CEO | Sell | 20,000 | $45.99 | $919,800.00 | -8.9% | |
| Dec 12, 2017 | NVS Novartis AG | Novartis Institutes For Biomedical Research, Inc. | 10% Owner | Sell | 1,523,000 | $18.30 | $27,870,900.00 | -26.9% | |
| Dec 12, 2017 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 23,681 | $45.02 | $1,066,225.18 | -50.3% | |
| Dec 12, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.96 | $9,916.92 | -1.7% | |
| Dec 11, 2017 | LLY Eli Lilly & Co | Simmons Jeffrey N52 | SVP&Pres. Elanco Animal Health | Sell | 12,500 | $86.46 | $1,080,750.00 | -9.1% | |
| Dec 8, 2017 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 12,312 | $3.30 | $40,629.60 | -1.6% | |
| Dec 8, 2017 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | Director | Buy | 5,000 | $6.21 | $31,050.00 | +0.7% | |
| Dec 8, 2017 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,955 | $75.00 | $221,625.00 | -18.3% | |
| Dec 8, 2017 | COLL Collegium Pharmaceutical, Inc | Hirsch David | Director, 10% Owner | Sell | 1,000,000 | $17.34 | $17,340,000.00 | -30.1% | |
| Dec 8, 2017 | COLL Collegium Pharmaceutical, Inc | Longitude Capital Partners, LLC | 10% Owner | Sell | 1,000,000 | $17.34 | $17,340,000.00 | -30.1% | |
| Dec 7, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Shohet Stephen B. | Director | Sell | 7,862 | $18.34 | $144,209.52 | -24.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.